Skip to main content
. 2022 Aug 24;10(9):1378. doi: 10.3390/vaccines10091378
ACE-2 angiotensin-converting enzyme 2
CKD chronic kidney disease
CX3CL1 CX3C chemokine receptor 1
COVID-19 the coronavirus 2019 disease
ELISA enzyme-linked immunosorbent assay
ESRD end stage renal disease
IgG immunoglobulin G
INF-γ interferon gamma
IS indoxyl sulfate
NF-κB nuclear factor kappa-light-chain-enhancer of activated B cells
NLRP3 NOD-, LRR- and pyrin domain-containing protein 3
RBD receptor binding domain
SARS-CoV-2 severe acute respiratory syndrome coronavirus 2
sVNT surrogate virus neutralization test